How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gruppo-italiano-per-la-valutazione-degli-interventi-in-terapia-intensiva.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Piperacillin-tazobactam combination product	Piperacillin-tazobactam combination product	marketed	Beta-lactam antibiotic with beta-lactamase inhibitor	Penicillin-binding proteins (PBPs); bacterial beta-lactamases	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Asian Institute of Gastroenterology, India · 1 shared drug class
Bayer · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hospital Italiano de Buenos Aires · 1 shared drug class
Imperial College London · 1 shared drug class
Kaizen Bioscience Co. · 1 shared drug class
Maggiore Bellaria Hospital, Bologna · 1 shared drug class
Albany Medical College · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva:

Cite this brief

Drug Landscape (2026). Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gruppo-italiano-per-la-valutazione-degli-interventi-in-terapia-intensiva. Accessed 2026-05-17.